Moreover, IL-1β antibody treatment decreases plaque stability indices in Apoe−/− mice with advanced atherosclerosis, indicating an unexpected role of IL-1β in regulating fibrous cap formation56. This evidence concerns the gene IL1B and atherosclerosis.